Please use this identifier to cite or link to this item:
|Title:||Inhibiting S100B(ββ) for activating wild-type p53 : design of stapled peptides||Authors:||Kannan, Srinivasaraghavan
Aronica, Pietro G. A.
Tan, Yaw Sing
Verma, Chandra Shekhar
|Keywords:||Science::Biological sciences||Issue Date:||2019||Source:||Kannan, S., Aronica, P. G. A., Tan, Y. S., & Verma, C. S. (2019). Inhibiting S100B(ββ) for activating wild-type p53 : design of stapled peptides. ACS Omega, 4(3), 5335-5344. doi:10.1021/acsomega.9b00097||Journal:||ACS Omega||Abstract:||S100B(ββ) is a member of the S100B protein family and is distributed in a cell-specific manner. Its levels are elevated in several cancers such as malignant melanoma and correlate directly with poor prognosis in patients. S100B(ββ) directly interacts with the tumor suppressor p53, inhibiting tetramerization and protein kinase C-dependent phosphorylation, consequently decreasing p53 DNA binding and transcriptional activity, and preventing apoptosis. Thus, S100B(ββ) is being pursued as a target for therapeutic inhibition. However, development of small molecule inhibitors targeting p53-interactions has met with limited success. In this work, we present a set of designed stapled peptide inhibitors of S100B(ββ), guided by the structure of the C-terminal domain of p53 complexed with S100B(ββ). We further modified a tightly binding stapled peptide with imaging agents and propose these as potential diagnostic agents to detect S100B(ββ) as a biomarker.||URI:||https://hdl.handle.net/10356/137422||ISSN:||2470-1343||DOI:||10.1021/acsomega.9b00097||Rights:||© 2019 American Chemical Society. This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||SBS Journal Articles|
Files in This Item:
|Inhibiting S100B(ββ) for Activating Wild-Type p53_Design of Stapled Peptides.pdf||6.57 MB||Adobe PDF||View/Open|
Updated on Jul 11, 2022
Updated on Jul 6, 2022
Updated on Aug 8, 2022
Updated on Aug 8, 2022
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.